HSTAX
Price
$106.38
Change
-$0.07 (-0.07%)
Updated
Sep 20 closing price
VFIAX
Price
$527.71
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

HSTAX vs VFIAX

Header iconHSTAX vs VFIAX Comparison
Open Charts HSTAX vs VFIAXBanner chart's image
Hartford Stock HLS IA
Price$106.38
Change-$0.07 (-0.07%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$527.71
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HSTAX vs VFIAX Comparison Chart
Loading...
VS
HSTAX vs. VFIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSTAX is a Buy and VFIAX is a Buy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.24T vs. HSTAX (1.39B). VFIAX pays higher dividends than HSTAX: VFIAX (1.32) vs HSTAX (1.17). HSTAX was incepted earlier than VFIAX: HSTAX (47 years) vs VFIAX (24 years). HSTAX is a more actively managed with annual turnover of: 8.00 vs. VFIAX (2.00). HSTAX has a lower initial minimum investment than VFIAX: HSTAX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 31.72 vs. HSTAX (19.56). VFIAX return over 5 years is better than : 90.47 vs. HSTAX (28.00).
HSTAXVFIAXHSTAX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence47 years24 years-
Gain YTD10.32619.97152%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B1.24T0%
Annual Yield % from dividends1.171.3288%
Returns for 1 year19.5631.7262%
Returns for 3 years5.6930.9918%
Returns for 5 years28.0090.4731%
Returns for 10 years105.04190.4855%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLBD54.491.17
+2.19%
Blue Bird Corp
MPLX44.200.07
+0.16%
Mplx LP
AIP7.45-0.08
-1.06%
Arteris
FFIN38.10-0.74
-1.91%
First Financial Bankshares
TPST1.35-0.06
-4.26%
Tempest Therapeutics